An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease
Clinical trial NCT05543252 · TERMINATED
Trial details
- NCT number
- NCT05543252
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-29
- Primary completion
- 2025-03-18
- Enrollment
- 428
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.